120 related articles for article (PubMed ID: 2897767)
1. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
Gergely L; Czeglédy J; Váczi L
Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
[TBL] [Abstract][Full Text] [Related]
2. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
[TBL] [Abstract][Full Text] [Related]
3. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj SH; Lerner AM; Fitzgerald JT
J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
5. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
Boppana SB; Britt WJ
Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
[TBL] [Abstract][Full Text] [Related]
6. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins.
Van Zanten J; Lazzarotto T; Campisi B; Vornhagen R; Jahn G; Landini MP; The TH
New Microbiol; 1995 Apr; 18(2):223-8. PubMed ID: 7603351
[TBL] [Abstract][Full Text] [Related]
8. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G
J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
Jankowski M; Styczyński P
Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo.
Bego MG; Keyes LR; Maciejewski J; St Jeor SC
Arch Virol; 2011 Oct; 156(10):1847-51. PubMed ID: 21625978
[TBL] [Abstract][Full Text] [Related]
11. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
[TBL] [Abstract][Full Text] [Related]
13. PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients.
Navalpotro D; Gimeno C; Navarro D
J Clin Virol; 2006 Feb; 35(2):193-6. PubMed ID: 16125456
[TBL] [Abstract][Full Text] [Related]
14. A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen.
Forman SJ; Zaia JA; Clark BR; Wright CL; Mills BJ; Pottathil R; Racklin BC; Gallagher MT; Welte K; Blume KG
J Immunol; 1985 May; 134(5):3391-5. PubMed ID: 2580024
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
Shen S; Wang S; Britt WJ; Lu S
Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
[TBL] [Abstract][Full Text] [Related]
17. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in patients with AIDS using a modified western blot.
Braun W; Weber B; Moell U; Hamann A; Doerr HW
J Virol Methods; 1993 Jun; 43(1):65-75. PubMed ID: 8395539
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum.
Ruellan-Eugene G; Barjot P; Campet M; Vabret A; Herlicoviez M; Muller G; Levy G; Guillois B; Freymuth F
J Med Virol; 1996 Sep; 50(1):9-15. PubMed ID: 8890034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
